companies / tripairtechnology-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-19 json
| total_raised | 6,510,0006.5M | ○ |
|---|---|---|
| founded | 2013 | |
| hq | Petah Tikva, Israel | |
| industry | unknown | |
| stage | null |
Coramaze develops Tripair, a minimally invasive transcatheter system to repair the tricuspid valve in patients with tricuspid regurgitation. It targets the many patients with severe tricuspid regurgitation who go untreated because existing therapies are too complex. It is designed to be as simple as a right-heart catheterization so any interventionalist can perform it, spun out of the University of Essen.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-02-01 | grant | 2,700,0002.7M | null | ○ |
LiteSpeed, PHP 8.3.31, WordPress, AitThemes, Lenis 1.1.13, Yoast SEO 26.3, WP Rocket 3.20.0.3, MySQL
| fact | status | src |
|---|---|---|
| Grant, $2.7M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |